Inhibition of VEGF receptor 2 increased cell death of dentate hilar neurons after traumatic brain injury

Experimental Neurology

Volumn 220, Issue 2, 2009, Pages 400-403

  Lee, Cheol ^a   Agoston, Denes V ^a  

^a Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center   (United States)

Author keywords

Hilar neurons; Neuroprotection; Traumatic brain injury; VEGF; VEGFR2

Indexed keywords

RECOMBINANT VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; DENTATE GYRUS; DRUG MECHANISM; MALE; NERVE CELL NECROSIS; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; TRAUMATIC BRAIN INJURY;

ANIMALS; BRAIN INJURIES; CELL DEATH; DENTATE GYRUS; FLUORESCENT DYES; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; INDOLES; INJECTIONS, INTRAVENTRICULAR; MALE; NEURONS; NEUROPROTECTIVE AGENTS; ORGANIC CHEMICALS; PROTEIN KINASE INHIBITORS; PYRROLES; RATS; RATS, SPRAGUE-DAWLEY; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 71549165126     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2009.08.019     Document Type: Article

References (34)

1. Amaral D.G. A Golgi study of cell types in the hilar region of the hippocampus in the rat. J. Comp. Neurol. 182 (1978) 851-914
2. Amaral D.G., Scharfman H.E., and Lavenex P. The dentate gyrus: fundamental neuroanatomical organization (dentate gyrus for dummies). Prog. Brain Res. 163 (2007) 3-22
3. Annegers J.F., Hauser W.A., Coan S.P., and Rocca W.A. A population-based study of seizures after traumatic brain injuries. N. Engl. J. Med. 338 (1998) 20-24
4. Caveness W.F. Epilepsy, a product of trauma in our time. Epilepsia 17 (1976) 207-215
5. Choi J.S., Kim H.Y., Cha J.H., Choi J.Y., Chun M.H., and Lee M.Y. Upregulation of vascular endothelial growth factor receptors Flt-1 and Flk-1 in rat hippocampus after transient forebrain ischemia. J. Neurotrauma 24 (2007) 521-531
6. Choi Y.S., Lin S.L., Lee B., Kurup P., Cho H.Y., Naegele J.R., Lombroso P.J., and Obrietan K. Status epilepticus-induced somatostatinergic hilar interneuron degeneration is regulated by striatal enriched protein tyrosine phosphatase. J. Neurosci. 27 (2007) 2999-3009
7. Gerber H.P., McMurtrey A., Kowalski J., Yan M., Keyt B.A., Dixit V., and Ferrara N. Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation. J. Biol. Chem. 273 (1998) 30336-30343
8. Greenberg D.A., and Jin K. From angiogenesis to neuropathology. Nature 438 (2005) 954-959
9. Houser C.R. Interneurons of the dentate gyrus: an overview of cell types, terminal fields and neurochemical identity. Prog. Brain Res. 163 (2007) 217-232
10. Kawai T., Takagi N., Mochizuki N., Besshoh S., Sakanishi K., Nakahara M., and Takeo S. Inhibitor of vascular endothelial growth factor receptor tyrosine kinase attenuates cellular proliferation and differentiation to mature neurons in the hippocampal dentate gyrus after transient forebrain ischemia in the adult rat. Neuroscience 141 (2006) 1209-1216
11. Kharatishvili I., Nissinen J.P., McIntosh T.K., and Pitkanen A. A model of posttraumatic epilepsy induced by lateral fluid-percussion brain injury in rats. Neuroscience 140 (2006) 685-697
12. Kilic E., Kilic U., Wang Y., Bassetti C.L., Marti H.H., and Hermann D.M. The phosphatidylinositol-3 kinase/Akt pathway mediates VEGF's neuroprotective activity and induces blood brain barrier permeability after focal cerebral ischemia. FASEB J. 20 (2006) 1185-1187
13. Kilic U., Kilic E., Jarve A., Guo Z., Spudich A., Bieber K., Barzena U., Bassetti C.L., Marti H.H., and Hermann D.M. Human vascular endothelial growth factor protects axotomized retinal ganglion cells in vivo by activating ERK-1/2 and Akt pathways. J. Neurosci. 26 (2006) 12439-12446
14. Lowenstein D.H., Thomas M.J., Smith D.H., and McIntosh T.K. Selective vulnerability of dentate hilar neurons following traumatic brain injury: a potential mechanistic link between head trauma and disorders of the hippocampus. J. Neurosci. 12 (1992) 4846-4853
15. Manoonkitiwongsa P.S., Schultz R.L., McCreery D.B., Whitter E.F., and Lyden P.D. Neuroprotection of ischemic brain by vascular endothelial growth factor is critically dependent on proper dosage and may be compromised by angiogenesis. J. Cereb. Blood Flow Metab. 24 (2004) 693-702
16. Matsuzaki H., Tamatani M., Yamaguchi A., Namikawa K., Kiyama H., Vitek M.P., Mitsuda N., and Tohyama M. Vascular endothelial growth factor rescues hippocampal neurons from glutamate-induced toxicity: signal transduction cascades. FASEB J. 15 (2001) 1218-1220
17. McIntosh T.K., Vink R., Noble L., Yamakami I., Fernyak S., Soares H., and Faden A.L. Traumatic brain injury in the rat: characterization of a lateral fluid-percussion model. Neuroscience 28 (1989) 233-244
18. Ogunshola O.O., Antic A., Donoghue M.J., Fan S.Y., Kim H., Stewart W.B., Madri J.A., and Ment L.R. Paracrine and autocrine functions of neuronal vascular endothelial growth factor (VEGF) in the central nervous system. J. Biol. Chem. 277 (2002) 11410-11415
19. Oosthuyse B., Moons L., Storkebaum E., Beck H., Nuyens D., Brusselmans K., Van Dorpe J., Hellings P., Gorselink M., Heymans S., Theilmeier G., Dewerchin M., Laudenbach V., Vermylen P., Raat H., Acker T., Vleminckx V., Van Den Bosch L., Cashman N., Fujisawa H., Drost M.R., Sciot R., Bruyninckx F., Hicklin D.J., Ince C., Gressens P., Lupu F., Plate K.H., Robberecht W., Herbert J.M., Collen D., and Carmeliet P. Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration. Nat. Genet. 28 (2001) 131-138
20. Pencea V., Bingaman K.D., Wiegand S.J., and Luskin M.B. Infusion of brain-derived neurotrophic factor into the lateral ventricle of the adult rat leads to new neurons in the parenchyma of the striatum, septum, thalamus, and hypothalamus. J. Neurosci. 21 (2001) 6706-6717
21. Rosenstein J.M., and Krum J.M. New roles for VEGF in nervous tissue-beyond blood vessels. Exp. Neurol. 187 (2004) 246-253
22. Sköld M.K., von Gertten C., Sandberg-Nordqvist A.C., Mathiesen T., and Holmin S. VEGF and VEGF receptor expression after experimental brain contusion in rat. J. Neurotrauma 22 (2005) 353-367
23. Sköld M.K., Risling M., and Holmin S. Inhibition of vascular endothelial growth factor receptor 2 activity in experimental brain contusions aggravates injury outcome and leads to early increased neuronal and glial degeneration. Eur. J. Neurosci. 23 (2006) 21-34
24. Sloviter R.S. Decreased hippocampal inhibition and a selective loss of interneurons in experimental epilepsy. Science 235 (1987) 73-76
25. Smolich B.D., Yuen H.A., West K.A., Giles F.J., Albitar M., and Cherrington J.M. The antiangiogenic protein kinase inhibitors SU5416 and SU6668 inhibit the SCF receptor (c-kit) in a human myeloid leukemia cell line and in acute myeloid leukemia blasts. Blood 97 (2001) 1413-1421
26. Sondell M., Sundler F., and Kanje M. Vascular endothelial growth factor is a neurotrophic factor which stimulates axonal outgrowth through the flk-1 receptor. Eur. J. Neurosci. 12 (2000) 4243-4254
27. Storkebaum E., Lambrechts D., Dewerchin M., Moreno-Murciano M.P., Appelmans S., Oh H., Van Damme P., Rutten B., Man W.Y., De Mol M., Wyns S., Manka D., Vermeulen K., Van Den Bosch L., Mertens N., Schmitz C., Robberecht W., Conway E.M., Collen D., Moons L., and Carmeliet P. Treatment of motoneuron degeneration by intracerebroventricular delivery of VEGF in a rat model of ALS. Nat. Neurosci. 8 (2005) 85-92
28. Sun Y., Jin K., Xie L., Childs J., Mao X.O., Logvinova A., and Greenberg D.A. VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia. J. Clin. Invest. 111 (2003) 1843-1851
29. Swartz B.E., Houser C.R., Tomiyasu U., Walsh G.O., DeSalles A., Rich J.R., and Delgado-Escueta A. Hippocampal cell loss in posttraumatic human epilepsy. Epilepsia 47 (2006) 1373-1382
30. Warner-Schmidt J.L., and Duman R.S. VEGF is an essential mediator of the neurogenic and behavioral actions of antidepressants. Proc. Natl. Acad. Sci. U S A 104 (2007) 4647-4652
31. Wu L.W., Mayo L.D., Dunbar J.D., Kessler K.M., Baerwald M.R., Jaffe E.A., Wang D., Warren R.S., and Donner D.B. Utilization of distinct signaling pathways by receptors for vascular endothelial cell growth factor and other mitogens in the induction of endothelial cell proliferation. J. Biol. Chem. 275 (2000) 5096-5103
32. Yasuhara T., Shingo T., Kobayashi K., Takeuchi A., Yano A., Muraoka K., Matsui T., Miyoshi Y., Hamada H., and Date I. Neuroprotective effects of vascular endothelial growth factor (VEGF) upon dopaminergic neurons in a rat model of Parkinson's disease. Eur. J. Neurosci. 19 (2004) 1494-1504
33. Yee K.W., O'Farrell A.M., Smolich B.D., Cherrington J.M., McMahon G., Wait C.L., McGreevey L.S., Griffith D.J., and Heinrich M.C. SU5416 and SU5614 inhibit kinase activity of wild-type and mutant FLT3 receptor tyrosine kinase. Blood 100 (2002) 2941-2949
34. Yourey P.A., Gohari S., Su J.L., and Alderson R.F. Vascular endothelial cell growth factors promote the in vitro development of rat photoreceptor cells. J. Neurosci. 20 (2000) 6781-6788